{"schemaVersion":"411.history/1","type":"revision","id":"7eea1b3ef1b42ffb1badec3e6d732d1bfb32110966ca513dd7034daa4bae51a7","itemId":"medworld411:aa8a7f0407bcf44d9a347964","legacyId":"aa8a7f0407bcf44d9a347964","nativeVersion":"history-v1:1","revision":1,"predecessor":null,"observedAt":"2026-11-21T02:50:31.410Z","contentHash":"d8f4f62c3485d6a5f47427e43ed45072b53765bc46d132e93712eb648047f9e2","content":{"title":"FDA Provides Clarity to Support Cell and Gene Therapy Development and Quality","url":"http://www.fda.gov/news-events/press-announcements/fda-provides-clarity-support-cell-and-gene-therapy-development-and-quality","sourceId":"fda","sourceName":"FDA","publishedAt":"2026-11-02T13:56:06.000Z","publishedDate":null,"publishedRaw":"Mon, 02 Nov 2026 08:56:06 EST","updatedRaw":null,"kind":"Official release","deadline":null,"topics":["care"],"section":"policy","classifierVersion":"medworld411.topics/1","vertical":null,"primaryUrl":"http://www.fda.gov/news-events/press-announcements/fda-provides-clarity-support-cell-and-gene-therapy-development-and-quality","coverageUrl":null},"provenance":{"captureScope":"headline-metadata","publisherEditTimeKnown":false,"importedAt":null,"completeness":"forward-capture-baseline; older native history retained separately"},"release":"0.2.1-vertical.1"}